SANKEI CHEMICAL, Dec-Aug (Cumulative 3Q) Ordinary Profit Increases by 2.3 times, Exceeds Full-Year Plan

SANKEI CHEMICAL CO.,LTD. <4995> [FSE] announced its financial results in the afternoon session on October 9th (14:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending November 2025 (December 2024 to August 2025) surged 2.3 times that of the same period last year, reaching 439 million yen. Progress toward the full-year plan of 273 million yen is 160.8%, already exceeding the target and also exceeding the same period of the previous year of 138.1%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary loss for the September to November period (4Q) is expected to expand to a loss of 166 million yen (compared to a loss of 53 million yen in the same period last year). However, if the fourth-quarter performance remains at the same level as the first three quarters, the full-year plan may be increased.

In the most recent three-month period, from June to August (3Q), the consolidated ordinary loss improved to a deficit of 31 million yen (compared to a loss of 92 million yen in the same period last year). The operating profit/loss margin improved from -9.0% in the same period last year to -6.1%.

Kabutan News